Background Multiple sclerosis (MS) is a chronic, demyelinating disease of the central
nervous system that results in progressive and irreversible disability. Fatigue is one of the …

Background Multiple sclerosis (MS) is an immune‐mediated disease of the central nervous
system affecting an estimated 1.3 million people worldwide. It is characterised by a variety of …

Patients with multiple sclerosis (PwMS) have a high level of fatigue and a reduced quality of
life (QoL) due to the impact of multiple sclerosis (MS). Virtual reality-based therapy (VRBT) is …

Background Fatigue is a common and debilitating symptom of Multiple Sclerosis (MS);
however, it is unknown what constitutes a clinically significant change in fatigue …

Objective The prevalence of multiple sclerosis (MS)-related fatigue may have changed due
to new diagnostic criteria and new disease modifying drugs. We aimed to assess the …

Introduction Fatigue is a common and debilitating symptom among multiple sclerosis (MS)
patients with a prevalence up to 81% and with a considerable impact on quality of life …

(1) Background: Multiple Sclerosis (MS) is a chronic, progressive, immune-mediated
disorder that affects the Central Nervous System and is the most common cause of non …

Background and objectives To define the boundaries and the overlaps between fatigue,
sleepiness and depression in patients with multiple sclerosis (MS) by using different tools for …

Objectives: To analyze work productivity loss and costs, including absenteeism (time missed
from work), presenteeism (reduced productivity while working), and unpaid work loss …

Fatigue is one of the most disabling symptoms of Multiple Sclerosis (MS), affecting more
than 80% of patients over the disease course. Nevertheless, it has a multi-faceted and …